Experts Warn HHS Vaccine Policy Changes Violate Law and Endanger Health

Feb 11, 2026, 2:35 AM
Image for article Experts Warn HHS Vaccine Policy Changes Violate Law and Endanger Health

Hover over text to view sources

Legal and public health experts have issued a strong warning regarding the recent decisions made by the US Department of Health and Human Services (HHS) to downgrade several vaccine recommendations. A brief filed in the case American Academy of Pediatrics et al. Kennedy outlines how these changes not only violate established federal laws but also pose a serious risk to public health, especially for vulnerable populations like children and pregnant individuals.
The HHS has notably downgraded the COVID-19 vaccine from a "routine" recommendation for all individuals aged six months and older. This has raised concerns about the potential increase in preventable diseases, as the agency has also dropped longstanding recommendations for universal hepatitis B vaccinations for newborns and reduced the number of childhood vaccines recommended for routine use from 17 to 11. Public health experts emphasize that vaccines have historically played a crucial role in preventing serious illnesses and deaths.
The implications of these changes are alarming. Joshua Sharfstein, a former FDA official and one of the legal scholars involved in the case, stated, "The law simply does not permit HHS to change vaccine recommendations for millions of American families on a dime." He stressed the importance of thorough evidence consideration and public discussion when it comes to vaccine policy, particularly as it affects children's health.
Furthermore, the shift in HHS's vaccine recommendations to a category known as "shared clinical decision-making" has created confusion for both families and healthcare providers. This designation is usually reserved for situations where the evidence regarding the risks and benefits of vaccination is unclear. Experts argue that this move undermines the established frameworks that govern vaccine policy, which require extensive public input and evidence gathering.
The recent lawsuit filed by the American Public Health Association (APHA) and several medical organizations challenges these changes, claiming they put Americans "at grave and immediate risk" of harm. The lawsuit specifically targets Secretary Robert F. Kennedy Jr for his role in these decisions, noting that he has a history of spreading vaccine misinformation. Critics argue that such actions not only contravene federal procedures but also threaten the integrity of public health initiatives designed to protect the population.
The legal complaint highlights that the directive issued by Kennedy lacks a solid scientific basis. According to experts, the COVID-19 vaccines have been shown through peer-reviewed studies to be safe and effective for children and pregnant individuals. The lawsuit asserts that the new guidance creates significant challenges for healthcare providers, who now find themselves in conflicting positions regarding vaccine recommendations.
Susan Kressly, president of the American Academy of Pediatrics, expressed concern that undermining vaccine recommendations could weaken the nation's vaccination infrastructure even further. She stated, "These actions are creating confusion around proven vaccines and the science supporting them," thereby endangering children's health and contributing to the spread of preventable diseases.
The lawsuit against HHS is part of a broader effort by public health advocates to restore trust in vaccinations and combat the rising tide of vaccine hesitancy exacerbated by misinformation. As vaccination rates decline, particularly among children, health officials warn of a potential resurgence of diseases that have been largely controlled through immunization.
In summary, the ongoing legal battles and public health warnings underscore the critical need for transparency, evidence-based policymaking, and adherence to established legal frameworks in the realm of vaccine recommendations. The health and well-being of millions depend on these decisions, and experts are calling for immediate action to rectify the changes made by HHS.

Related articles

West Virginia School Board Appeals Vaccine Exemption Ruling to Supreme Court

The West Virginia Board of Education has filed an appeal to the state Supreme Court, seeking to overturn a ruling that allows families with religious or philosophical objections to bypass mandatory school vaccinations. This case could significantly impact vaccination policies and public health in the state.

The Risks of a Mystic as Public Health Leader

The nomination of Casey Means as Surgeon General raises concerns about the implications of appointing a figure with mystical beliefs to a critical public health role. With a background that includes unconventional practices and a lack of active medical credentials, her leadership could undermine evidence-based health guidance in America.

RFK Jr.’s Vaccine Policy Changes Spark Controversy Among Health Groups

Recent changes to childhood vaccine recommendations under Health Secretary Robert F. Kennedy Jr have left health organizations scrambling to respond. The modifications, which include significant alterations to the MMRV and hepatitis B vaccine policies, have raised concerns about public health and the involvement of medical experts in the decision-making process.

Mayes & Bonta Challenge CDC's Vaccine Overhaul in New Lawsuit

Arizona Attorney General Kris Mayes and California Attorney General Rob Bonta are co-leading a multistate lawsuit against the CDC and HHS over a controversial overhaul of the childhood vaccination schedule. The complaint alleges that the new policies endanger public health and undermine decades of scientific evidence supporting routine immunizations.

Moderna's FDA Review Offers Hope Amid Political Challenges

Moderna has received a critical step forward from the FDA, as the agency will review its application for a new mRNA flu vaccine. However, the political environment surrounding vaccine approvals, influenced by key figures in the current administration, poses ongoing challenges for Moderna and other vaccine manufacturers.